Summary
This federal Q301 solicitation seeks a vendor to provide long-term specialized reference laboratory services for Measurable Residual Disease (MRD) detection in hematologic malignancies, on a Base Plus 4 Option Year basis covering the period September 1, 2026 through August 31, 2031. It was issued by the Department of Veterans Affairs through Network Contracting Office 16 (NCO 16) in support of the Michael E. DeBakey VA Medical Center (MEDVAMC) in Houston, TX. The contract covers all required MRD testing for hematologic malignancies at MEDVAMC for the base year plus four option years, with renewal pricing tied to the BLS Consumer Price Index for All Urban Wage Earners and Clerical Workers (CPI-W) for the Houston, Texas area.